Conversely, higher GLP1R expression correlates with poorer survival outcomes in cancers such as cervical squamous cell carcinoma, lung squamous cell carcinoma, stomach adenocarcinoma, and uterine corpus endometrial carcinoma. The gene discussed is GLP1R; the disease is cancer.